EVLO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EVLO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Evelo Biosciences's EBITDA per Share for the three months ended in Sep. 2023 was $-1.27.
During the past 3 years, the average EBITDA Per Share Growth Rate was 22.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 23.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Evelo Biosciences was 31.70% per year. The lowest was 5.20% per year. And the median was 15.05% per year.
For the Biotechnology subindustry, Evelo Biosciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Evelo Biosciences's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Evelo Biosciences's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
Evelo Biosciences (OTCPK:EVLO) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Thank you for viewing the detailed overview of Evelo Biosciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Simba Gill | director, officer: President & CEO | 515 GALVESTON DR, REDWOOD CITY CA 94063 |
Mark Bodmer | officer: See Remarks | C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139 |
Marella Thorell | officer: Chief Financial Officer | 1226 CHARTER LANE, AMBLER PA 19002 |
Duncan Mchale | officer: Chief Medical Officer | C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139 |
Alexander C Reynolds | director | C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139 |
Horizon Technology Finance Corp | 10 percent owner | 312 FARMINGTON AVENUE, FARMINGTON CT 06032 |
Jeffrey R. Moore | director | C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139 |
Flagship Ventures Fund Iv, L.p. | 10 percent owner | 55 CAMBRIDGE PARKWAY, 8TH FLOOR, CAMBRIDGE MA 02142 |
Robert L. Rosiello | director | 400 SOMERSET CORPORATE BOULEVARD, BRIDGEWATER NJ 08807 |
Stephen J Carriere | officer: Principal Accounting Officer | |
David R Epstein | director | INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 W. 57TH STREET, NEW YORK NY 10019 |
Lord Ara Darzi | director | C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139 |
Flagship Pioneering Fund Vii, L.p. | 10 percent owner | 55 CAMBRIDGE PARKWAY, 8TH FLOOR, CAMBRIDGE MA 02142 |
Flagship Pioneering Fund Vii General Partner Llc | 10 percent owner | 55 CAMBRIDGE PARKWAY, 8TH FLOOR, CAMBRIDGE MA 02142 |
Tonya Williams | director | C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, SUITE 200, CAMBRIDGE MA 02139 |
From GuruFocus
By Marketwired • 07-12-2023
By Value_Insider Value_Insider • 11-08-2022
By Marketwired • 07-10-2023
By GlobeNewswire GlobeNewswire • 09-01-2022
By PurpleRose PurpleRose • 08-11-2022
By Value_Insider Value_Insider • 11-15-2022
By PRNewswire • 11-17-2023
By PurpleRose PurpleRose • 07-11-2022
By PRNewswire PRNewswire • 11-07-2022
By GuruFocus Research • 11-14-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.